Precision treatment in advanced hepatocellular carcinoma

X Yang, C Yang, S Zhang, H Geng, AX Zhu… - Cancer Cell, 2024 - cell.com
The past decade has witnessed significant advances in the systemic treatment of advanced
hepatocellular carcinoma (HCC). Nevertheless, the newly developed treatment strategies …

A guide to artificial intelligence for cancer researchers

R Perez-Lopez, N Ghaffari Laleh, F Mahmood… - Nature Reviews …, 2024 - nature.com
Artificial intelligence (AI) has been commoditized. It has evolved from a specialty resource to
a readily accessible tool for cancer researchers. AI-based tools can boost research …

APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024

G Lau, S Obi, J Zhou, R Tateishi, S Qin, H Zhao… - Hepatology …, 2024 - Springer
Abstract In Asia–Pacific region, hepatocellular carcinoma is a serious health threat
attributing to over 600,000 deaths each year and account for over 70% of global cases …

[HTML][HTML] Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024

L Žigutytė, T Sorz-Nechay, J Clusmann, JN Kather - JHEP Reports, 2024 - Elsevier
Artificial Intelligence (AI) methods enable humans to analyze large amounts of data, which
would otherwise not be feasibly quantifiable. This is especially true for unstructured visual …

Challenges and Opportunities in the Clinical Translation of High-Resolution Spatial Transcriptomics

TM Pentimalli, N Karaiskos… - Annual Review of …, 2024 - annualreviews.org
Pathology has always been fueled by technological advances. Histology powered the study
of tissue architecture at single-cell resolution and remains a cornerstone of clinical …

Hepatocellular carcinoma immune microenvironment analysis: A comprehensive assessment with computational and classical pathology

C Ercan, SL Renne, L Di Tommaso, CKY Ng… - Clinical Cancer …, 2024 - aacrjournals.org
Purpose: The spatial variability and clinical relevance of the tumor immune
microenvironment (TIME) are still poorly understood for hepatocellular carcinoma (HCC). In …

Deep learning‐based accurate diagnosis and quantitative evaluation of microvascular invasion in hepatocellular carcinoma on whole‐slide histopathology images

X Zhang, X Yu, W Liang, Z Zhang, S Zhang… - Cancer …, 2024 - Wiley Online Library
Background Microvascular invasion (MVI) is an independent prognostic factor that is
associated with early recurrence and poor survival after resection of hepatocellular …

Artificial intelligence in liver cancer—new tools for research and patient management

J Calderaro, L Žigutytė, D Truhn, A Jaffe… - Nature Reviews …, 2024 - nature.com
Liver cancer has high incidence and mortality globally. Artificial intelligence (AI) has
advanced rapidly, influencing cancer care. AI systems are already approved for clinical use …

[HTML][HTML] Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies

T Lan, F Tacke - Metabolism, 2024 - Elsevier
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)
continues to rise, making it the leading etiology of chronic liver diseases and a prime cause …

From research to reality: The role of artificial intelligence applications in HCC care

IC Wiest, S Gilbert, JN Kather - Clinical Liver Disease, 2024 - journals.lww.com
Deep learning (DL) refers to the use of deep artificial neural networks to analyze complex
data. DL is the most widely used artificial intelligence (AI) method and is increasingly …